Rare diseases
Investigational molecules
Locations
Back to Italy475 clinical trials in Parma, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Thymalfasin for Adults with Cystic Fibrosis
ItalyStudy Comparing Ramucirumab with Irinotecan, Leucovorin, and 5-FU or Paclitaxel for Patients with Advanced Stomach or Gastroesophageal Cancer After Previous Chemotherapy
ItalyStudy on the Safety and Effectiveness of Fianlimab, Cemiplimab, and Chemotherapy in Adults with Resectable Non-Small Cell Lung Cancer
ItalyStudy on De-escalated Induction Therapy with Methotrexate, Cytarabine, Thiotepa, and Rituximab for Newly Diagnosed Primary CNS Lymphoma Patients
ItalyStudy of Atezolizumab and Drug Combination for Patients with Relapsed or Refractory Hodgkin's Lymphoma Eligible for Stem Cell Transplant
ItalyStudy on the Safety and Effectiveness of Metformin Hydrochloride, Dapagliflozin, and Canagliflozin in Elderly Patients with Type 2 Diabetes
ItalyStudy of EOS884448, Dostarlimab, and Inupadenant for Patients with Advanced Solid Tumors
ItalyStudy of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors
ItalyStudy on Prednisone and Vitamin D for Elderly Patients with Diffuse Large B-Cell Lymphoma
ItalyStudy of SBP-101, Nab-Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer
ItalyStudy of drug combination with gemcitabine, cisplatin, carboplatin and avelumab in patients with advanced urothelial cancer to evaluate response to platinum-based chemotherapy
ItalyStudy of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on multiple myeloma, lung cancer, and breast cancer treatments. Investigations include innovative immunotherapy approaches and targeted therapies for various cancer types.
Research emphasizes personalized treatment approaches and combination therapies to improve patient outcomes.
Studies examining treatments for respiratory syncytial virus (RSV) infections in high-risk populations. Advanced research into preventive therapies and management strategies.
Focus on developing protective measures for vulnerable patient populations.
Clinical trials evaluating new approaches to kidney transplantation and prevention of complications. Research on reducing delayed graft function and improving transplant outcomes.
Emphasis on enhancing long-term transplant success rates.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
